Acoustic neuroma is a benign primary intracranial tumor of the vestibulocochlear nerve. The majority of patients present with ipsilateral sensineuronal hearing loss. Gamma knife radiosurgery is the principal alternative to microsurgical resection for acoustic neuromas. The goals of radiosurgery are prevention of tumor growth, maintenance of neurologic function, and prevention of new neurologic deficits. This review was performed to evaluate the efficacy of gamma knife radisosurgery for symptoms caused by acoustic neuroma and resulting quality of life. We evaluated 70 consecutive patients currently living treated with gamma knife radiosurgery for acoustic neuroma between 1995 and 2008. Baseline symptoms were collected from the time of procedure along with details of the treatment plan including dose to 50% isodose line, number of isocenters, and cubic centimeters treated. Patients were then contacted by phone and asked to report on changes in symptoms, new symptoms, new interventions, employment, and general quality of life. They were also evaluated using the Spitzer quality of life survey which consisted of five questions scored 0–2. The mean age of patients at time of procedure was 58 years (31–82). Thirty-four were male and thirty-six were female. There were 32 right-sided lesions and 38 left-sided lesions. Sixty patients received gamma knife as primary treatment and ten for recurrence. Treatment characteristics found a mean dose of 13.7 Gy (12–18), mean number of isocenters of 7 (1–20), and a mean volume treated of 1.96 cc (0.1–13.8). Presenting symptoms included ipsilateral hearing loss (93%), tinnitus (20%), pain (16%), numbness (14%), and dizziness (7%). Median time to phone follow-up was 73 months (5–158). Majority of patients reported their symptoms as same (57.1%) or better (32.9%). Six patients (8.6%) reported new symptoms after treatment and of these only one required medical intervention (medication for facial twitch). Thirty-nine patients (55.7%) were employed at the time of procedure and of these 89.7% continued to work on follow-up. Overall activity was reported as same in 87.1% of patients. When asked about overall quality of life, 48.6% reported it as same, 37.1% reported it as somewhat better, and 10% reported it as much better. The mean score for the Spitzer QOL survey was 9.56 out of 10. When asked about expectations and general satisfaction regarding the procedure, 93% of patients felt that gamma knife radiosurgery met their expectations and 93% of patients would recommend this as a primary treatment for acoustic neuroma. These findings suggest that gamma knife radiosurgery is an effective primary modality for the treatment of acoustic neuroma in terms of control of symptoms, improved quality of life, and general patient satisfaction.
Read full abstract